Properties (60)
Predicate | Object |
---|---|
gptkbp:instanceOf |
gptkb:Company
|
gptkbp:acquisition |
Acquired_by_XYZ_Corp_in_2010
|
gptkbp:awards |
Best Workplace 2021
Innovation in Pharma 2022 |
gptkbp:benefits |
health insurance
flexible working hours paid time off retirement plans |
gptkbp:category |
antibiotics
pain management cardiovascular drugs diabetes medications neurology drugs |
gptkbp:CEO |
gptkb:Jane_Doe
|
gptkbp:clinicalTrials |
published in medical journals
Phase I, Phase II, Phase III collaboration with global research teams Phase_III_trials_for_drug_ABC |
gptkbp:collaborations |
with biotech firms
Partnership_with_ABC_Hospital |
gptkbp:community_outreach |
health fairs
|
gptkbp:communityPrograms |
scholarships for students
health education workshops internships for local youth support for local clinics |
gptkbp:conference |
Pharma Innovations 2023
|
gptkbp:employees |
500
|
gptkbp:founded |
1950
|
gptkbp:founder |
gptkb:John_Martin
|
gptkbp:funding |
$10 million in grants
|
gptkbp:future_plans |
increased investment in R&D
expansion into new markets development of new drugs |
gptkbp:global_presence |
offices_in_Asia
offices_in_Europe offices_in_South_America |
gptkbp:headquarters |
gptkb:New_York,_USA
|
https://www.w3.org/2000/01/rdf-schema#label |
Martin Drug Company
|
gptkbp:industry |
pharmaceuticals
|
gptkbp:investmentFocus |
$50 million in R&D
quarterly reports |
gptkbp:market |
gptkb:North_America
15% in oncology |
gptkbp:partnerships |
gptkb:University_of_Medicine
|
gptkbp:patentCitation |
20 active patents
|
gptkbp:philanthropy |
donations to health charities
|
gptkbp:products |
prescription drugs
|
gptkbp:regulatoryCompliance |
FDA_approved
ISO_certified |
gptkbp:research |
gptkb:Dr._Emily_Smith
|
gptkbp:research_focus |
oncology
|
gptkbp:revenue |
$200 million
|
gptkbp:social_responsibility |
community health initiatives
|
gptkbp:stockExchange |
MDC
|
gptkbp:subsidiary |
gptkb:Martin_Biotech
|
gptkbp:supplyChain |
global suppliers
|
gptkbp:sustainability_initiatives |
green packaging
|
gptkbp:targetMarket |
Drug XYZ in 2022
|
gptkbp:training |
ongoing professional development
|
gptkbp:website |
www.martindrugco.com
|